文献速递免疫规划

免疫途径和抗原对dmLT佐剂疫苗免疫原性的影响大于生化应激或制剂辅料

Route and antigen shape immunity to dmLT-adjuvanted vaccines to a greater extent than biochemical stress or formulation excipients.
PubMed 文献 · Vaccine · 2023-01-31

研究评估了黏膜佐剂dmLT在制剂稳定性改变后的免疫效果,用ETEC菌毛黏附素蛋白或灭活脊灰病毒经注射或黏膜途径免疫。结果显示免疫途径和共同接种抗原对疫苗免疫原性的影响大于dmLT制剂的稳定性或不稳定性,提示制剂优化需同时评估生化稳定性和疫苗诱导的免疫应答。

要点

  • 免疫途径和共同接种抗原对dmLT佐剂疫苗免疫原性的影响大于dmLT制剂稳定性。
  • 生化评估显示的dmLT聚集、亚基解离或稳定性改善需结合疫苗免疫原性验证。
  • 结果对dmLT的临床应用及资源匮乏地区的递送具有意义。

核心结论

  • 免疫途径和共同接种抗原对疫苗免疫原性的影响大于dmLT制剂的生化稳定性或不稳定性。

研究设计与样本

  • 研究评估了经生化方法鉴定为改善或降低黏膜佐剂dmLT稳定性的制剂,所用疫苗为ETEC菌毛黏附素蛋白或灭活脊灰病毒,免疫途径包括注射或黏膜接种。

主要发现

  • 制剂或热应激可引起dmLT蛋白发生聚集或亚基解离等生化改变,特定缓冲液组成可抵抗这些变化。
  • 经注射或黏膜接种ETEC菌毛黏附素蛋白或灭活脊灰病毒后,免疫途径和共同接种抗原对疫苗免疫原性的影响大于dmLT制剂稳定性或不稳定性的影响。

临床怎么用

  • 作者认为制剂优化中应同时进行生化评估和疫苗诱导的免疫评估。
  • 作者指出这些研究结果对dmLT在临床环境中的使用及在资源匮乏环境中的递送具有意义。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A key aspect to vaccine efficacy is formulation stability. Biochemical evaluations provide information on optimal compositions or thermal stability but are routinely validated by ex vivo analysis and not efficacy in animal models. Here we assessed formulations identified to improve or reduce stability of the mucosal adjuvant dmLT being investigated in polio and enterotoxigenic E. coli (ETEC) clinical vaccines. We observed biochemical changes to dmLT protein with formulation or thermal stress, including aggregation or subunit dissociation or alternatively resistance against these changes with specific buffer compositions. However, upon injection or mucosal vaccination with ETEC fimbriae adhesin proteins or inactivated polio virus, experimental findings indicated immunization route and co-administered antigen impacted vaccine immunogenicity more so than dmLT formulation stability (or instability). These results indicate the importance of both biochemical and vaccine-derived immunity assessment in formulation optimization. In addition, these studies have implications for use of dmLT in clinical settings and for delivery in resource poor settings.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Stone AE, Rambaran S, Trinh IV, et al. Route and antigen shape immunity to dmLT-adjuvanted vaccines to a greater extent than biochemical stress or formulation excipients. Vaccine. 2023. PMID: 36732163. doi:10.1016/j.vaccine.2023.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。